This is what we have been waiting for, FDA approval shall follow along. No word about the financial side of the agreement like if there is any equity investment. Waiting for this agreement has held revenue back but now Roche can starting promoting the tests and be totally on top of things when approval finally comes through. Between Roche and 3M we will see some good revenue growth over the next year. Other tests are in the works and will build this company in the years ahead.

~~dimar